Prediction of hemorrhagic transformation after recanalization therapy using T2*-: Permeability magnetic resonance imaging

被引:114
作者
Bang, Oh Young
Buck, Brian H.
Saver, Jeffrey L.
Alger, Jeffry R.
Yoon, Sa Rah
Starkman, Sidney
Ovbiagele, Bruce
Kim, Doojin
Ali, Latisha K.
Sanossian, Nerses
Jahan, Reza
Duckwiler, Gary R.
Vinuela, Fernando
Salamon, Noriko
Villablanca, J. Pablo
Liebeskind, David S.
机构
[1] Univ Calif Los Angeles, Stroke Ctr, Dept Neurol, Los Angeles, CA 90095 USA
[2] Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Seoul, South Korea
[3] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Dept Emergency Med, Los Angeles, CA USA
关键词
D O I
10.1002/ana.21174
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Predicting hemorrhagic transformation (HT) is critical in the setting of recanalization therapy for acute stroke. Dedicated magnetic resonance imaging (MRI) sequences for detection of increased blood-brain barrier (BBB) permeability recently have been developed. We evaluated the ability of a novel MRI permeability technique to detect baseline derangements predictive of various forms of HT after recanalization therapy. Methods: We retrospectively analyzed the clinical and pretreatment MRI data on patients undergoing recanalization therapy for acute cerebral ischemia at a university medical center from January 2004 to November 2006. Pretreatment MRI permeability images derived from perfusion source data were compared with posttreatment imaging to evaluate whether baseline BBB permeability derangements may predict HT after recanalization therapy. The use of a novel permeability technique to illustrate BBB derangements was based on the detection of decreased signal intensity at later time points in perfusion MRI acquisition, signifying continued local accumulation of contrast caused by leakage. Results: Among 32 patients, some degree of FIT occurred in 12. Permeability image abnormalities at baseline were present in 7 of 12 patients with HT and none of the 20 patients without HT on follow-up images. The sensitivity of permeability abnormality for parenchymal hematoma was 83%. False-negative findings were noted in five cases, most commonly asymptomatic or minor HT after mechanical clot retrieval. Interpretation: Permeability images derived from pretreatment perfusion MRI source data may identify patients at risk for HT with high specificity. Our preliminary demonstration of permeability imaging based on standard perfusion data for prediction of hemorrhage merits further study with dedicated MRI BBB permeability acquisitions and multicenter validation.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 23 条
[1]   Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study [J].
Albers, Gregory W. ;
Thijs, Vincent N. ;
Wechsle, Lawrence ;
Kemp, Stephanie ;
Schlaug, Gottfried ;
Skalabrin, Elaine ;
Bammer, Roland ;
Kakuda, Wataru ;
Lansberg, Maarten G. ;
Shuaib, Ashfaq ;
Coplin, William ;
Hamilton, Scott ;
Moseley, Michael ;
Marks, Michael P. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :508-517
[2]   Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke [J].
Alsop, DC ;
Makovetskaya, E ;
Kumar, S ;
Selim, M ;
Schlaug, G .
STROKE, 2005, 36 (04) :746-750
[3]   Hemorrhagic transformation of ischemic brain tissue -: Asymptomatic or symptomatic? [J].
Berger, C ;
Fiorelli, M ;
Steiner, T ;
Schäbitz, WR ;
Bozzao, L ;
Bluhmki, E ;
Hacke, W ;
von Kummer, R .
STROKE, 2001, 32 (06) :1330-1335
[4]   Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
Miller, R ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R .
STROKE, 1997, 28 (11) :2109-2118
[5]  
Cha S, 2006, AM J NEURORADIOL, V27, P409
[6]  
FISHER CM, 1951, J NEUROPATH EXP NEUR, V10, P92
[7]  
Hacke W, 2004, LANCET, V363, P768
[8]   Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke - The PROACT II trial [J].
Kase, CS ;
Furlan, AJ ;
Wechsler, LR ;
Higashida, RT ;
Rowley, HA ;
Hart, RG ;
Molinari, GF ;
Frederick, LS ;
Roberts, HC ;
Gebel, JM ;
Sila, CA ;
Schulz, GA ;
Roberts, RS ;
Gent, M .
NEUROLOGY, 2001, 57 (09) :1603-1610
[9]  
Kassner A, 2005, AM J NEURORADIOL, V26, P2213
[10]   Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? [J].
Kent, DM ;
Ruthazer, R ;
Selker, HP .
STROKE, 2003, 34 (02) :464-467